In many jurisdictions, organ allocation is done on the basis of the health status of the patient, either explicitly or implicitly. This paper presents a self-promoting priority queueing model for patient waiting times which takes into account changes in health status over time. In this model, most patients arrive as "regular" customers to the queue, but as the health of a patient degrades, their status is promoted to "priority" to reflect the increased urgency of the transplant. We model the queueing system as a level-dependent quasi-birth-and-death process, and the steady-state joint queue length distribution as well as the marginal delay distributions for each queue are computed via the use of matrix analytic techniques. The model is calibrated using liver transplantation wait-list data, provided by a regional health centre in Canada, that tracked approximately 1,100 patients over nearly 13 years. Blood-type specific models are fit and performance measures, such as the mean and distribution of the time until transplant, are obtained and compared to empirical estimates calculated using the raw data.
Introduction
Solid organ transplantation is a therapy that is used widely around the world, to treat patients whose life expectancy can be meaningfully increased by the replacement of one or more organs that are failing. During the half century or so that transplantation has been a viable option in the treatment of patients with a failing organ, wait lists have been established for patients awaiting a suitable organ. In many jurisdictions, these wait lists have operated under a variety of modifications to the first come, first transplanted (FCFT) discipline, to account for the patient's health status. In recent years, however, patterns have developed which specifies this modification in a formal way. For example, Wiesner et al. [27] developed the "Model for End-stage Liver Disease (MELD) Score" as a means for ranking patients periodically so that those whose health status was degrading more quickly would gain priority access to a deceased-donor liver. The resulting service discipline used for the liver transplant wait lists does not fit into the realm of existing FCFT or priority queueing models, since a wait-listed patient's priority depends upon their health status, which in turn is influenced by the amount of time they have spent waiting.
Delays while patients await transplantation are frequently lengthy, often on the order of years, as has been observed by numerous authors for multiple organ types in a variety of jurisdictions. A sample of these studies follows which gives an indication of the variety of contexts in which this problem has been recognized: kidneys in Germany (Glander et al. [7] and Liefeldt et al. [18] ), hearts in the UK (Hussey et al. [9] ), kidneys in the US (Zenios et al. [29] ), and livers in the US (Barone et al. [2] ) and in Canada (Stanford et al. [21] ).
Despite this fact, the use of analytical queueing models specifically to address transplant waiting times on the wait lists has been somewhat limited. The goal of this paper is to present a full analysis and application of a queueing model which we develop for livertransplant patients of each ABO blood type that reflects the sickest patient first aspect and allows for abandonments. We derive the steady-state queue length and marginal delay distributions. We derive estimators for the parameters, and we calibrate and assess the fit of the model using real wait-list data. Our work demonstrates how queueing theory can produce a model which can be used to provide a reasonable indication of key performance measures, such as the likelihood of successful transplantation (either prior to or after a degradation in health status), and the likelihood of abandonment or of death while waiting.
Zenios [28] appears to have been the first to present a queueing model for transplant waiting times. This queueing model was used in turn by Zenios et al. [29] in their study of kidney transplant wait lists in the US. The kidney allocation problem was revisited by Su and Zenios [23] , from the perspective of customer choice. Further details on the specific assumptions of these papers follows later on in this section.
Stanford et al. [21] combined a statistical analysis of patient placements and deceaseddonor organ availability with a section presenting simple queueing models to assess the consequences of three strategies to try to close a well-documented gap between the demand Recently, Stanford et al. [22] used a queueing model to respond to a recent development in addressing the so-called "Blood Type O Problem" (see [7] ), in which too many type O organs are cross-transplanted to compatible blood groups, causing notably longer waits for blood type O recipients due to the reduced supply of O organs. Glander et al. [7] noted that this frequently has led to situations in which blood type O recipients experience worse health outcomes in terms of statistically-significant higher mortality rates during their longer waiting times. The authors also observed that there are "poorer graft outcomes" for type O recipients as a result. The analysis in [7] and [18] led to a change in the kidney transplant policy employed by the the Eurotransplant zone effective late 2011, insisting upon ABO-identical transplantation. Aware of this development, Stanford et al. [22] developed a construct called the "Array of Idealized Transplant Queues (AITQ)", which was used to show that an ABO-identical transplant policy would be incapable in the long run of delivering comparable waiting times for all blood groups in the Canadian context (and by implication, any jurisdiction with a close match to the Canadian blood mix of 46% O, 42% A, 9% B, and 3% AB -see [5] ). While ABO-identical transplantation would indeed resolve the blood type O problem, it would replace it with an even worse problem for patients of blood types B and AB, due to the relative rarity of these organs in the population at large. The analysis in [22] established that ABO-identical transplantation would lead to delays typically five (respectively, fifteen) times longer for blood group B (respectively, AB) patients in Canada and other countries with a close mix of blood types in the population.
We note as an aside that there are also studies involving simulations from queueing models which have been used to numerically examine the behaviour of kidney transplant wait lists; we note in particular the work of Abellán et al. [1] in this regard. However, we will not be considering simulation models in the remainder of this paper.
The goal of Stanford et al. [22] was to establish the long-run inability of an ABOidentical transplantation policy to deliver comparable waiting times for all blood groups.
The question being addressed was the long-run system waiting time experience of the four blood groups, rather than individual patient experience. As such, its purpose was to address transplant policy, whereas the present paper has as its goal the development of a queueing model to assess patient waiting times on the wait lists. In our view, all of the previous models have either ignored or inadequately described one key aspect of deceased-donor transplant wait lists or another, as we now review. The interested reader is advised to also review the text in [22] where the distinguishing factors which arise in transplant queue settings are discussed at some length.
The first such factor is queue abandonment: the tendency for patients to leave the wait list due to death, a degradation in health status, personal reasons, or even in some cases, improvement in patient health to the point where transplantation is no longer the preferred therapy. Stanford et al. [22] commented upon, but did not incorporate a mechanism for abandonments, as it affects all blood groups, and as such had secondary impact upon the blood type issue they addressed. Zenios [28] did account for abandonments, but did so at an exponential rate independent of the queue length, as opposed to a rate that is proportional to the number on the wait lists, which is a feature of the model we present herein.
The second factor is the service discipline: the fact that many transplant queues do not at present typically follow a FCFT discipline, but instead treat wait-listed patients who experience a degradation in health status on a priority basis (so long as they are still candidates for transplantation). None of the foregoing transplant papers reflected this priority aspect, which we attempt to do by invoking the idea of patients who "self promote" from regular status to priority status at an exponential rate, while waiting. The "self-promoting" literature is fairly extensive, comprising Krishnamoorthy and Narayanan [11] , Wang [26] , Gómez-Corral et al. [8] , and Krishnamoorthy et al. [12, 13, 14, 15] . In telecommunication systems, the idea of promoting packets with low priority status to the high priority queue is referred to as "priority jumps" and has been studied in the recent past as well (e.g., see Maertens et al. [19] , and references therein).
It is our view that a third factor, not adequately discussed in the queueing models apart from [22] , is the fundamental role that patient and donor ABO status plays in determining individual patient waiting time experience. We feel it needs to be explicitly factored into the wait time modelling, as we do, for most jurisdictions in the world. A particular exception might be the US case, where the transplant system comprises a large network of centres arranged nationally, regionally, and locally, in which organs are procured under the Organ Procurement and Transportation Network (OPTN) and allocated under the rules of the United Network of Organ Sharing (UNOS). The UNOS rules include aspects which indicate under what circumstance compatible transplantation is allowed or not alongside the decisions about where the organ will be allocated. The complicated nature of these interactions of the various levels tends to obscure the role that blood type plays in the US environment. In most jurisdictions that we are aware of, such as Canada and the Eurotransplant zone, organs are routinely allocated on an ABO-identical basis. Rules for access to ABO-compatible organs on the basis of urgent need vary depending on the organ to be transplanted and the jurisdiction. The numerical examples we present, which considers the experience of one particular Canadian liver transplantation centre, reflects the fact that there are interlinked wait lists. The principal way that this will manifest itself herein is that, in the data used for model calibration, we will aggregate both ABO-identical and ABO-compatible organs that were transplanted into patients of each of the four blood types.
We remark that the model presented herein is one for deceased-donor transplant wait lists. It is true that transplanted kidneys and livers can come from deceased donors or living ones. Widely known in the case of kidneys, this is also true for the liver, one lobe of which can be grafted into the recipient, while the donor retains the other. While livingdonor transplantation could be viewed as another type of abandonment from the queue, such abandonments are planned, not random. We do not directly address the issue of such planned transplants in our model. In summary, the pursuit of a suitable analytical queueing model to infer a likely waiting time for patients awaiting a deceased-donor organ transplantation is both timely and warranted, given the importance of the problem. The present paper is the first we are aware of to address the sickest patient first aspect, and to adequately address the question of abandonments. Such a model would be useful for decision makers to explore qualitatively the impact of various changes that could arise on the waiting times experienced by individual patients, in advance of such changes taking place. An example of potential decision makers, but by far not the only ones, would be teams of medical professionals and performance modellers interested in exploring the impact of the types of changes we list below.
Examples of policy changes that would likely impact waiting time include such aspects as: (i) the merging of formerly separate wait lists, (ii) changes in policies regarding ABOidentical versus ABO-compatible cross-transplantation, or the controlled policies in this regard in light of Stanford et al. [22] , (iii) a decrease in deceased donor organ rates due to improvements in accident prevention, and (iv) in the case of kidneys, a change in demand for deceased donor organs (and possibly the blood mix of the remaining recipients on the list) due to the increased use of "transplant chains" involving living donors. Other like examples can be thought of readily.
The present work presents a model for patients of each ABO blood type, reflecting the factors stated above, that can be used to provide a reasonable indication of the relative likelihood of the possible outcomes that individual patients can experience: successful transplantation prior to perceived health degradation, successful transplantation as a priority patient due to health degradation, the likelihood of abandonment or death while waiting, etc., as well as estimates of the time spent waiting.
The rest of the paper is organized as follows. In the next section, the details of our queueing model are specified. In Section 3, the underlying steady-state distribution for the model is obtained. Delay distributions for high-priority (HP) and low-priority (LP) wait-listed patients are investigated in the subsequent two sections. Section 6 develops estimators for the model parameters using a maximum-likelihood-based approach under a competing risks framework. Section 7 presents the results from an initial case study of real liver transplantation wait-list data: blood-type specific models are fit to this data and model-based performance measures are compared to qualitatively assess goodness of fit.
The paper ends with some observations and concluding remarks in Section 8.
Description of the Queueing Model
Consider the queueing model depicted in Figure 1 in which a single server provides service to two classes (class 1 and class 2) of transplant requests, each having its own respective line. Wait-listed patients are served on a FCFT basis within their own line. As organ availability is always the limiting factor, the service time constitutes the interval from when a wait-listed patient reaches the head of their queue until an organ becomes available to him/her. Furthermore, class 1 has preemptive priority over class 2, implying that a class-2 patient in service (i.e., next in line to receive an organ) would be preempted by an arriving class-1 patient to the system. Let m < ∞ and n < ∞ be the buffer sizes of the LP and HP queues, respectively.
Figure 1: Proposed Queueing Model
We define λ 1 and λ 2 to be the respective (independent) Poisson arrival rates of HP and LP patients to the system. We allow for different service rates for HP and LP patients, both for reasons of generality, and to reflect situations in which patients with an urgent need for transplant have wider access to deceased-donor organs. Let µ 1 and µ 2 be the (individual) independent and exponentially distributed HP and LP service rates, respectively.
We distinguish between the reneging/abandonment behaviours of the two patient classes. At the class-1 level, reneging patients leave the system at rate α 1 and are unrecoverable (reflecting deaths and "coming off-list"). In contrast, at the class-2 level, patients renege at rate α 2 , and either leave the system with probability q (for patients who die or come off-list) or are immediately promoted to the end of the HP queue with probability p = 1 − q (reflecting degraded health status still suitable for transplantation). Once in the HP queue, further reneging for such promoted patients occurs at the class-1 rate α 1 . Note that a patient who reaches the service stage is still subject to potential reneging (since service constitutes waiting for an organ to become available).
The concept of self-generation of priorities was proposed by Krishnamoorthy and Narayanan [11] and subsequently analyzed in a series of papers by Wang [26] , Gómez-Corral et al. [8] , and Krishnamoorthy et al. [12, 13, 14, 15] , most of which essentially concern a model where regular customers in a multi-server, single class queue would "selfpromote" at a constant rate while waiting, independently of other customers in the queue.
A self-promoted customer would displace any non-priority item in service. For the foregoing models, in the event that no regular customers were found in service, the promoted customer leaves the queue to obtain urgent service elsewhere. In contrast, our self-promoted customers join the HP queue and only immediately depart the system if no waiting space is available in the HP queue.
In this paper, we determine the following main performance measures associated with our queueing model: (ii) The cumulative distribution function (CDF) and moments related to the stationary waiting time W * H of an originally-arriving HP patient who successfully completes service prior to reneging, obtained in Section 4.
(iii) The CDF and moments related to the stationary waiting time W * L,1 of an arriving LP patient who successfully completes service within the LP queue prior to reneging, obtained in Section 5.
(iv) The CDF and moments related to the stationary waiting time W * L,2 of a promoted LP patient from the point of transfer to the HP queue until that patient successfully completes service prior to reneging, obtained also in Section 5.
(v) The probabilities HP Renege, LP Renege, and P romLP Renege representing the various likelihoods that a patient reneges prior to receipt of an organ. Specifically, HP Renege is the probability that a patient who arrives as HP will renege, LP Renege is the reneging probability for a LP patient, and P romLP Renege is the reneging probability for a HP patient who initially arrived as LP. These probabilities are determined in Sections 4 and 5.
Determination of the Steady-state Probabilities
Our first objective is to determine the steady-state joint probabilities {π i,j ; i = 0, 1, . . . , m, j = 0, 1, . . . , n}, where π i,j = P r(X L = i, X H = j). We say that the process is "at level i" whenever X L = i. For k ≥ 0, we define the k th steady-state probability row vector (of dimension n + 1) to be
be the concatenated steady-state probability row vector having a total of m + 1 levels. To determine π, we need to solve0 = πQ where Q is the infinitesimal generator of the process and0 = (0, 0, . . . , 0) is the concatenated row vector (having a total of m + 1 levels) in which 0 denotes a 1 × (n + 1) row vector of zeros.
With X L serving as the level of the process (and X H as the sub-level), we note that Q is block-structured with blocks Q i,j (of size n + 1) containing all transitions where X L changes from i to j. Due to the presence of reneging in the model and the fact that X L can only change by ±1, we end up with a level-dependent quasi-birth-and-death (QBD) process having infinitesimal generator of the form
In (1) above, 0 denotes an appropriately dimensioned square matrix of zeros (which, in this case, is of dimension n + 1). The overall dimension of Q is (m + 1)(n + 1) × (m + 1)(n + 1).
identity matrix. Moreover, it readily follows that
For notational convenience, we define λ = λ 1 + λ 2 , β i = µ 1 + iα 1 , and
let e k be a 1 × k row vector with 1 as the first entry and zeros everywhere else. Based on this notation, the diagonal components of Q can be expressed as
Level-dependent QBDs have been well-studied in the literature (e.g., see Bright and
Taylor [4] ), and it is possible to adapt a computational procedure proposed by Gaver et al. [6] to calculate the steady-state probabilities associated with our model, which we now summarize below. The equilibrium equations in block form are as follows:
Solving (3) and (4) in a backward fashion ultimately yields
where the set of matrices {R j } m j=1 satisfy the recursive relation
with
The summation of all the probabilities can be expressed as
where 1 ′ k , in general, denotes a k × 1 column vector of ones. Factoring out π 0 from (7) and defining the column vector
and (7) give rise to the following system of linear equations which must be solved to determine π 0 , namely:
In (8) and 1 × (n + 2), respectively. Once π 0 is determined, we obtain π i , i ≥ 1, via (5).
Delay Distributions for HP Transplant Requests
We focus initially on the stationary distribution of a random variable W H , representing the duration of time from the arrival of an external HP patient to the system until this patient successfully completes service. We refer to W H as the "nominal" HP patient delay, as we implicitly assume that there is room in the HP queue for the arriving patient to enter the system, and that the arriving HP patient is not subject to reneging. (Later on, we will incorporate the reneging behaviour of this patient in our analysis.)
Define the following conditional steady-state probabilities, given that a random HP arrival is able to enter the HP queue: Poisson-arriving HP patient finds the system in state (i, j) with probability θ i,j . Therefore, conditioning on the state of the system encountered upon entry, we obtain
Due to the nature of the preemptive service rule in place, the quantity Pr(
does not depend upon the number of LP transplant requests present upon arrival of our tagged HP patient, so that (9) reduces to
where θ •,j = ∑ m i=0 θ i,j denotes the marginal distribution of the HP queue length. With X H = j, we observe that W H initially consists of the total time required to clear the j class-1 patients ahead of the newly-arriving HP patient. Since all class-1 patients ahead of this HP patient might renege (including the one receiving service at rate µ 1 ), the total delay (including the service time of our tagged HP patient) can be represented by
The resulting distribution is a member of the phase-type family of distributions (e.g., see Latouche and Ramaswami [16] , Chapter 2), so that
where T j+1 is a (j + 1) × (j + 1) matrix of the form
Substituting (11) into (10), it is possible to express the distribution of W H in terms of a single, succinct phase-type representation of dimension n, namely
where Θ n is the 1 × n row vector given by
We now incorporate the reneging behaviour that our tagged HP patient can exhibit while residing in the system. Let W * H denote the "actual" HP patient delay, representing the arriving HP patient's total time spent in system (which incorporates successfully completing service prior to reneging). 
Note that the denominators of (13) and (14) involve a quantity which we denote by
representing the probability our tagged HP patient abandons the HP queue prior to an organ becoming available to him/her.
Delay Distributions for LP Transplant Requests
We next determine stationary delay distributions associated with the arrival of an arbitrary LP patient to the system. First of all, we focus our attention on a random variable W L,1 , which we define as the duration of time from the arrival of a LP patient to the system until this patient successfully completes service within the LP queue. Therefore, as in the definition of W H from the previous section, we refer to W L,1 as the nominal LP patient delay and likewise assume that there is room in the LP queue for the arriving patient to enter the system, and that the arriving LP patient is not subject to reneging. (We will incorporate the reneging behaviour of this patient in our analysis later.)
We begin by defining similar conditional steady-state probabilities, namely
We next introduce several row vectors required in the subsequent analysis. First of all, we define δ i to be a 1 × (n + 1) row vector with 1 in position i, i = 1, 2, . . . , n + 1, and zeros everywhere else. Next, let (ii) Phase j -the number j of LP patients who queue behind our tagged LP patient,
(iii) Sub-phase k -the number k of HP patients present in the system, k = 0, 1, . . . , n.
Based on the permissible values that i, j, and k can assume, one can readily verify that the cardinality of this state space equals ℓ, the total number of elements comprising the row vector Φ.
In regard to this state space partitioning, the form of the matrix R is given by
In (15) 
where D, the (n + 1) × (n + 1) matrix governing the state transitions in which the number of queued LP patients behind our tagged LP patient decreases by one, is given by 
and "⊗" denotes the Kronecker product operator.
Finally, to obtain the diagonal blocks of A i (i.e., the rate matrices F
in which the only state transitions occur within the HP queue) for i = 0, 1, . . . , m − 1, we make use of our earlier assumption that the tagged LP patient does not renege, and the fact that the row sums of P must be equal to 0. This enables us to determine
With these pieces in place, the time to absorption in such a Markov chain is once again phase-type distributed, and so the CDF of W L,1 is given by
However, we now incorporate the reneging behaviour of the tagged LP patient by defining W * L,1 to be the actual LP delay (i.e., the arriving LP patient's total time spent in system to achieve successful service within the LP queue). Clearly,
where R L denotes an exponentially distributed random variable, independent of W L,1 , with mean 1/α 2 . Following the same approach which led to the derivation of (13) and (14), we ultimately obtain
We remark that the denominators of (16) and (17) involve the LP reneging probability
We next turn our attention to characterizing the distribution of W L,2 , which we define as the nominal delay experienced from the point of transfer to the HP queue of a promoted LP patient until that patient successfully completes service. We remark that this distribution will look different than that which is perceived by the externally-arriving class-1 stream, as the instants at which promotions occur is clearly dependent upon the present length of the LP queue. However, conditional on encountering j class-1 patients ahead of the promoted LP patient, the results of the previous section can still be applied to ascertain that the nominal delay the promoted patient experiences in order to complete service is phase-type distributed with rate matrix given by (12) . The difference will lie in the initial probability vector to use in connection with this phase-type distribution, as Θ n from the previous section is no longer appropriate.
As a means of identifying the proper initial probability vector to use, we track the potential path our tagged LP patient can take with respect to three distinct final outcomes (or dispositions) within the LP queue. We label these final outcomes as follows: F 1 ≡ tagged LP patient completes successful service in the LP queue, F 2 ≡ tagged LP patient reneges and exits the system from the LP queue, and F 3 ≡ tagged LP patient receives promotion to the HP queue.
The event F 3 can be further broken down into elemental final outcomes F 3 = {f n , f n−1 , . . . , f 0 }, where f i represents the outcome in which our tagged LP patient finds i class-1 patients ahead of it upon promotion. Note that f n represents the outcome that the HP queue is full at the instant of promotion. As a matter of completeness, we include f n in the set F 3 (although its associated probability will be singled out later on as a blocking probability of interest). Let ∆ F = {F 1 , F 2 , f n , f n−1 , . . . , f 0 } be the set of states corresponding to these final outcomes. Also, let ∆ L represent the set of states corresponding to our tagged LP patient residing in the LP queue, having the same state space partitioning as the rate matrix R above. In order to track which of these final outcomes the tagged LP patient ultimately experiences, we introduce the following Markov chain with underlying
where S = R − α 2 I ℓ . Recall that the matrix R given by (15) did not take into account the reneging behaviour of our tagged LP patient. However, our current treatment necessitates the incorporation of this reneging behaviour, and as such, the definition of S includes the additional term −α 2 I ℓ . Furthermore, the block-structured matrix T is given by
We wish to determine the absorption probabilities into each of the n + 1 states of F 3 , which we denote by ψ(f i ), i = 0, 1, . . . , n. This is accomplished by analyzing the embedded Markov chain (or jump process) associated with the above continuous-time Markov chain.
Specifically, the (one-step) transition probability matrix of the associated jump process is given by (e.g., see Syski [24] , p. 14)
where diag(S) denotes the matrix containing only diag(S)'s diagonal entries. The fundamental matrix (e.g., see Pinsky and Karlin [20] , p. 142) associated with (18) works out to
from which it readily follows that
where T ′ n+3−i denotes the (n+3−i) th column of T , i = 0, 1, . . . , n. Of particular relevance is the quantity ψ(f n ), which represents the probability that the tagged LP patient encounters a full HP queue at the instant of its promotion (and is thus denied entry and subsequently exits the system). In other words, ψ(f n ) is another blocking probability of interest. In keeping with our earlier choice of notation, we also let P romLP Block = ψ(f n ).
Clearly,
∑ n i=0 ψ(f i ) = p · LP Renege, and so the 1 × n row vector
) contains the (normalized) probabilities for the number of potential HP patients present in the HP queue at the instant that the LP patient is successfully promoted to the HP queue.
With this analogue of Θ n in hand, we make use of the phase-type distributional results of the previous section to immediately obtain
In addition, the associated delay distribution defined by the conditional random variable
where P romLP Renege = α 1 Ψ n (α 1 I n − T n ) −1 1 ′ n represents the probability that a selfpromoted LP patient leaves the system prior to an organ becoming available to him/her.
Model Calibration Via a Parametric Competing Risks Framework
Solid organ transplantation wait-list data differs from the usual queueing perspective in several aspects. A patient's arrival time, waiting time, and service time are still tracked, but there are additional complications due to both abandonments (e.g., deaths and coming off-list) and self-promotion in priority due to health degradation. In this context, the cause for a patient to leave the queue needs to be tracked as well as their time in the system; such data can be modelled using a "competing risks" framework (e.g., see Kalbfleisch and Prentice [10] or Lawless [17] ).
To be specific, we are interested in simultaneously modelling more than one event time variable. Consider the arrival of a LP patient, who can exit the LP queue either by obtaining a transplanted organ, or by reneging (i.e., promotion to the HP queue, death, or recovery to off-list status). If such a patient left the system as a result of obtaining a transplanted organ, we know not only the exact time of this event, but we also know that their time to renege would have been longer (i.e., their reneging time is right-censored). Conversely, had the patient reneged, then their time to transplant would have been right-censored.
We have assumed that external arrivals to both queues follow independent Poisson processes and that the transplant and reneging times are exponentially distributed. In this parametric modelling context, it is possible to construct a likelihood function that incorporates the notion of a competition between the class-specific transplantation and reneging rates. Given data, the model can then be calibrated by estimating the parameters using a maximum-likelihood-based approach. The suitability of assuming exponential interavailability times was discussed at length in Stanford et al. [21] , and that result was employed in [22] to show why it is reasonable to make that assumption in the presence of random ABO-compatible transplantation.
Consider the case of two generic competing risks represented by the event time random variables T 1 and T 2 . When the observed times {t i ; i ∈ Z + } can be viewed as independent,
In (19) above, δ i is an indicator function taking the value 1 if the i th event was due to the type 1 event, and 0 if it was due to the type 2 event, while f T j (·) and F T j (·), j = 1, 2, are used to denote the respective probability density and cumulative distribution functions for the two competing event times.
It is not possible to directly employ the likelihood approach outlined above using T 1 as the system time of a LP patient and T 2 as the corresponding time to renege, because the system times of successive patients are not independent. Rather, they are highly correlated since successive system times in a heavily-loaded queue will have a great degree of overlap.
Instead, we consider the sequence of observed "inter-exit times" within each priority stream, which we assume are at least approximately independent.
Calibration of the LP stream using maximum likelihood based on the sequence of ob- Due to the memoryless property of the exponential distribution, each residual time to transplant remains exponentially distributed at rate µ 2 . Each residual time until the first abandonment from the LP queue is also still exponentially distributed (because it is the minimum of a finite number of independent exponential random variables), but at an accelerated rate of α 2 (t) = N 2 (t)α 2 , where N 2 (t) represents the random number of LP patients waiting at time t. In this context, the likelihood function for the LP stream is approximately proportional to
The likelihood function given by (20) is an approximation, because we do not allow for N 2 (t) to vary during an inter-exit time due to new arrivals to the LP queue. To further simplify our estimation scheme, we assume a fixed value for the LP queue size, setting N 2 (t) = N 2 ∈ Z + . Our rationale for this restriction is that, although there is fluctuation in the LP queue size, it appeared to remain fairly constant in the liver transplant data we consider in the next section.
Given such data, the maximum likelihood estimates (MLEs), obtained by maximizing the log-likelihood (with respect to the parameters), are as follows:
We observe that if there were no abandonments and no censoring, the estimated service rate would be the reciprocal of the average service time, as one would expect from a random sample of an exponential distribution.
In our framework, the probability p of being promoted to HP status occurs at random.
LP patients who renege are considered to either immediately "self-promote" to the HP queue with probability p, or to exit the system with probability q = 1 − p, independently of the others. The total number of reneging LP patients who become promoted is thus a binomial random variable, whose MLEp is well known to be the empirical proportion of "successes". In our context,p is the observed proportion of reneging LP patients who receive promotion to the HP queue.
The calibration of the HP stream follows by analogy to the LP case described above.
The LP and HP streams are analyzed separately due to the assumption that HP patients are served on a FCFT basis, regardless as to how they entered that queue. Suppose that there were n 1 customers who entered the HP queue, either directly as a new arrival or through reneging from the LP queue, and that these observations are indexed by j. The resulting MLEs for the HP parameters arê
where δ * j is an indicator function taking the value 1 if the j th HP patient successfully achieved service, {t j ; j ∈ Z + } are the observed inter-exit times in the HP queue, and N 1 is the (assumed) number of HP patients present in the queue at any given instant.
Finally, the class-specific arrivals are assumed to follow separate, homogeneous Poisson processes and we assume patients arrive independently to the queueing system. In this context, the MLEs are clearlyλ 1 = n 1 /S andλ 2 = n 2 /S, where S denotes the length of the study period.
Case Study: Analysis of Liver Transplantation Data
In this section, we present an analysis of liver transplantation wait-list data provided by a regional health centre in Canada, under its Research Ethics Board guidelines for secondary use of anonymous information. Anonymous parameters were derived from a data set of nearly 1,100 patients who were on that region's liver wait list from January 2000 through December 2012, inclusive. A status and date profile was provided for each patient. This information tracked changes to each patient's CanWAIT (Canadian wait-listing algorithm in transplantation) status for human livers over the duration of their stay on the wait list. The ordinal set of CanWAIT status codes for a human liver are described in Table 1 (adapted from Bazarah et al. [3] , Table 2 ).
As noted in [3] , donor livers are typically allocated and transplanted regionally. However, patients with a CanWAIT status of 3F, 4, or 4F are considered "high-status patients", and are placed on a national wait list. Donor livers are directed to these patients as they become available from anywhere in the country. We categorized such patients as our HP patients, while the remaining patients with CanWAIT scores of 1, 1T, 2, or 3 were considered to be LP patients. Patients with initial scores in this range, whose health subsequently degraded to a 3F, 4, or 4F status, were considered to be LP patients who self-promoted to the HP queue. If a patient was placed "on hold" (a CanWAIT score of 0), we assumed their priority in the queue did not change during the period they were in that status. In addition, although some short-duration oscillations between the LP and HP states were observed in the records of some patients, these were ignored and those patients were treated as if they stayed in the originating priority stream for the entire period in question. has been reported in other jurisdictions (e.g., see Glander et al. [7] , Liefeldt et al. [18] , and other references listed in Stanford et al. [22] ). The estimates also suggest that there is about one HP placement for every 5 LP placements for blood types O and B, and about one HP placement for every 6 LP placements for blood type A.
The model was run under three scenarios (i.e., for each of blood types O, A, and B), corresponding to the sets of parameter estimates given in Table 2 . The buffer sizes used for our model, along with the corresponding set of blocking probabilities obtained, are displayed in Table 3 for each blood-type specific case. We remark that the chosen values for m and n yield negligible blocking probabilities in all cases. Table 3 : Blood-type specific buffer sizes used and blocking probabilities obtained for the study data.
self-promoted to the HP queue, the "system time" we display starts at the moment of promotion. Typically, the percentiles estimated from the models are similar to the corresponding empirical percentiles. The empirical results for blood type B are more variable, which is not suprising as this blood type is less common. Less than a dozen patients with type B blood self-promoted from LP to HP, which explains why the bottom panel of Figure   3 is not as smooth as the empirical cumulative distribution functions for types O and A.
Whereas our HP results might be described as adequate, the same could not be said for the LP queue. In contrast to the consistency of the HP results, Figure 4 For the type B model, the opposite is observed and there is close agreement for the reneging rates of patients who entered directly as HP. Table 5 : Model-based and empirical-based estimates of the mean system times (measured in days) for patients who were successfully transplanted, along with their corresponding standard deviations (SDs). Results are given for each of the blood-type specific models.
The system times for three different types of patients are considered: direct-entry HP patients, self-promoted LP patients, and LP patients who never left the LP queue.
there are some patients who appear to spend a very long time in the LP queue, without abandoning that queue or self-promoting to the HP queue due to health degradation, who eventually get successfully transplanted.
Overall, these results seem to suggest that our model of LP system time fails to capture the high observed variability in waiting times, and the HP models are generally overly conservative. Future work will need to pursue all of the following avenues: revisiting the model assumptions regarding placement and abandonment rates, refining the parameter estimates, and testing the model against observed data from other wait lists. Nonetheless, we remark that a queueing model would still be a useful decision-making tool if it could be used qualitatively to explore the impact of various policy changes. Its use is not primarily a matter of forecasting the likelihood of delays as experienced by individual patients placed on the wait list.
Concluding Remarks
We have presented a model for estimating patient waiting times in deceased-donor transplant queues, which reflects both the propensity for patients to renege from the queue, and to self-promote to urgent status. Performance measures of interest we obtain include the waiting time distributions and their moments, the queue length distributions, and the reneging probabilities. These results are obtained for patients who are urgent when placed on the wait list, for those who have a regular status and receive their organ in regular status, and for those regular status placements who become urgent prior to transplantation.
In addition to the probabilistic results, which take the form of matrix geometric solutions for the queue lengths and phase-type distributions for the waiting times, we also have presented a maximum-likelihood-based procedure for estimation of the model parameters.
These results were then applied to study a single liver transplantation centre in Ontario.
Whereas the fit of waiting time for patients transplanted with an urgent status appeared to be appropriate, the fit for the regular stream of patients was deemed inadequate, since it appeared that the wait list comprised three priority classes operationally. Future work will proceed along two directions. On the one hand, we hope to be able to apply the data to other transplantation centres, to see if our two-class priority model is appropriate. On the other, we plan to extend the existing results to allow for a third priority class. The approach would parallel the methodology used in the two-class case.
We remind readers that some of the estimates in the previous section were based on the analysis of relatively small samples of data, in particular for the case of blood type B in the overall population. Furthermore, we felt that our estimates of AB data were too imprecise to be reliable, as they were based on too few data values. More precise estimates could be obtained through an analysis of longer records or through analysis of data from multiple health centres over the same study period.
Our model's assumption that all blood types have the same propensity to renege per unit time waiting is consistent with the medical view that blood type does not influence health degradation. Nonetheless, the longer a patient waits, the greater the chance for that patient to experience degraded health. The results obtained from our model suggest a substantial discrepancy in the HP reneging rate for blood type B than for blood types O and A; however, once again one needs to view this in the context of small numbers of urgent patients of all blood types. It would seem that further work to statistically estimate the abandonment parameters is called for.
Finally, it is clear that donor allocation in transplantation is a complex system depending on several interacting clinical and administrative events. We believe we have shown that this system is, despite its complexity, amenable to logical analysis using standard queueing theory. Further work is needed in terms of adequate parameter estimation, and other possible refinements to the modelling assumptions noted above may be needed after further numerical investigations. Results for each of the blood-type specific models appear in separate panels. 
